mFOLFOX6-Bevacizumab Regimen
**Semantic type:** Therapeutic or Preventive Procedure
**Definition:** A regimen consisting of bevacizumab and a modified version of the FOLFOX6 regimen (mFOLFOX6), which contains leucovorin, infusional fluorouracil and oxaliplatin, that may be used for the treatment of ampullary and appendiceal adenocarcinoma, colorectal cancer, and small bowel adenocarcinoma.
**Synonyms:** - Bevacizumab Plus mFOLFOX6 - Bevacizumab-mFOLFOX6 - Modified FOLFOX6-Bevacizumab - mFOLFOX6 Plus Bevacizumab - mFOLFOX6-Avastin - mFOLFOX6-B - mFOLFOX6-B (L-Leucovorin) (bevacizumab-tnjn) - mFOLFOX6-B (bevacizumab-adcd) - mFOLFOX6-B (bevacizumab-awwb) - mFOLFOX6-B (bevacizumab-aybi) - mFOLFOX6-B (bevacizumab-bvzr) - mFOLFOX6-B (bevacizumab-equi) - mFOLFOX6-B (bevacizumab-maly) - mFOLFOX6-B (bevacizumab-onbe) - mFOLFOX6-B (bevacizumab-tnjn) - mFOLFOX6-Bevacizumab - mFOLFOX6/Bevacizumab
/api/v1/systems/nci_thesaurus/nodes/C192028Hierarchy Explorer
Cross-system equivalences0
No cross-system equivalences mapped for this node.